{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:36:32Z","timestamp":1791311792752,"version":"4.3.1"},"reference-count":41,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,2,1]]},"DOI":"10.1210\/jc.2002-020400","type":"journal-article","created":{"date-parts":[[2003,2,6]],"date-time":"2003-02-06T20:45:23Z","timestamp":1044564323000},"page":"542-549","source":"Crossref","is-referenced-by-count":96,"title":["Risedronate Prevents New Vertebral Fractures in Postmenopausal Women at High Risk"],"prefix":"10.1210","volume":"88","author":[{"given":"Nelson B.","family":"Watts","sequence":"first","affiliation":[{"name":"University of Cincinnati (N.B.W.), Cincinnati, Ohio 45219"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Josse","sequence":"additional","affiliation":[{"name":"St. Michael\u2019s Hospital (R.G.J.), University of Toronto, Toronto, Ontario, Canada M5C 2T2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Hamdy","sequence":"additional","affiliation":[{"name":"East Tennessee State University (R.C.H.), Johnson City, Tennessee 37614"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney A.","family":"Hughes","sequence":"additional","affiliation":[{"name":"St. Peter\u2019s Hospital (R.A.H.), Chertsey KT16 0PZ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Manhart","sequence":"additional","affiliation":[{"name":"Procter & Gamble Pharmaceuticals (M.D.M., I.B.), Mason, Ohio 45040"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Barton","sequence":"additional","affiliation":[{"name":"Procter & Gamble Pharmaceuticals (M.D.M., I.B.), Mason, Ohio 45040"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Calligeros","sequence":"additional","affiliation":[{"name":"Medical Diagnostics Australia (D.C.), Sydney 2204, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Felsenberg","sequence":"additional","affiliation":[{"name":"Free University Berlin, University Hospital Benjamin Franklin (D.F.), Centre of Muscle and Bone Research, 12200 Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041116320593700_R1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy.","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"2019041116320593700_R2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0002-9343(97)90025-5","article-title":"Clinical consequences of vertebral fractures.","volume":"103","author":"Ross","year":"1997","journal-title":"Am J Med"},{"key":"2019041116320593700_R3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.7326\/0003-4819-128-10-199805150-00001","article-title":"The association of radiographically detected vertebral fractures with back pain and function: a prospective study.","volume":"128","author":"Nevitt","year":"1998","journal-title":"Ann Intern Med"},{"key":"2019041116320593700_R4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/jbmr.5650070413","article-title":"Contribution of vertebral deformities to chronic back pain and disability.","volume":"7","author":"Ettinger","year":"1992","journal-title":"J Bone Miner Res"},{"issue":"24 Suppl","key":"2019041116320593700_R5","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1097\/00007632-199712151-00002","article-title":"Epidemiology of spinal osteoporosis","volume":"22","author":"Melton III","year":"1997","journal-title":"Spine"},{"key":"2019041116320593700_R6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S8756-3282(99)00202-1","article-title":"Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures: effect of number and spinal location of fractures.","volume":"25","author":"Nevitt","year":"1999","journal-title":"Bone"},{"key":"2019041116320593700_R7","doi-asserted-by":"crossref","first-page":"919","DOI":"10.7326\/0003-4819-114-11-919","article-title":"Pre-existing fractures and bone mass predict vertebral fracture incidence in women.","volume":"114","author":"Ross","year":"1991","journal-title":"Ann Intern Med"},{"key":"2019041116320593700_R8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","article-title":"Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis.","volume":"15","author":"Klotzbuecher","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2019041116320593700_R9","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/bmj.309.6960.991","article-title":"Vertebral deformities as predictors of non-vertebral fractures.","volume":"309","author":"Burger","year":"1994","journal-title":"BMJ"},{"key":"2019041116320593700_R10","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1359\/jbmr.1999.14.5.821","article-title":"Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures.","volume":"14","author":"Black","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2019041116320593700_R11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/jama.285.3.320","article-title":"Risk of new vertebral fracture in the year following a fracture.","volume":"285","author":"Lindsay","year":"2001","journal-title":"JAMA"},{"key":"2019041116320593700_R12","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. A randomized controlled trial.","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"2019041116320593700_R13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis.","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteoporos Int"},{"key":"2019041116320593700_R14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women.","volume":"344","author":"McClung","year":"2001","journal-title":"New Engl J Med"},{"key":"2019041116320593700_R15","first-page":"1895","article-title":"Risedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial.","volume":"85","author":"Fogelman","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"2019041116320593700_R16","first-page":"S69","article-title":"Risedronate prevents bone loss in early postmenopausal women","volume":"64","author":"Hooper","year":"1999","journal-title":"Calcif Tissue Int"},{"key":"2019041116320593700_R17","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1359\/jbmr.2000.15.6.1006","article-title":"Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial.","volume":"15","author":"Reid","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2019041116320593700_R18","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K","article-title":"Risedronate therapy prevents corticosteroid-induced bone loss.","volume":"42","author":"Cohen","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2019041116320593700_R19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF01623271","article-title":"Prevalence and incidence of vertebral deformities.","volume":"3","author":"Melton III","year":"1993","journal-title":"Osteoporos Int"},{"key":"2019041116320593700_R20","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique.","volume":"8","author":"Genant","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2019041116320593700_R21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s001980050093","article-title":"Updated data on proximal femur bone mineral levels of US adults.","volume":"8","author":"Looker","year":"1998","journal-title":"Osteoporos Int"},{"key":"2019041116320593700_R22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF01623272","article-title":"Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women.","volume":"3","author":"Ross","year":"1993","journal-title":"Osteoporos Int"},{"key":"2019041116320593700_R23","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/jbmr.5650081010","article-title":"Long-term fracture prediction by bone mineral assessed at different skeletal sites.","volume":"8","author":"Melton III","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2019041116320593700_R24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0140-6736(93)92555-8","article-title":"Bone density at various sites for prediction of hip fractures.","volume":"341","author":"Cummings","year":"1993","journal-title":"Lancet"},{"key":"2019041116320593700_R25","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/1529-0131(199906)42:6<1246::AID-ANR22>3.0.CO;2-U","article-title":"Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group.","volume":"42","author":"Hochberg","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2019041116320593700_R26","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/jcem.87.4.8415","article-title":"Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents.","volume":"87","author":"Hochberg","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041116320593700_R27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1210\/jcem.85.1.6267","article-title":"Antifracture efficacy of antiresorptive agents are related to changes in bone density.","volume":"85","author":"Wasnich","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041116320593700_R28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial.","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"issue":"Suppl 2","key":"2019041116320593700_R29","first-page":"S203","article-title":"BMD change explains only a fraction of the observed fracture risk reduction in risedronate-treated patients","volume":"11","author":"Watts","year":"2000","journal-title":"Osteoporos Int"},{"key":"2019041116320593700_R30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9343(00)00490-3","article-title":"A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study.","volume":"109","author":"Chesnut","year":"2000","journal-title":"Am J Med"},{"key":"2019041116320593700_R31","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1002\/sim.984","article-title":"A method to assess the proportion of treatment effect explained by a surrogate endpoint.","volume":"20","author":"Li","year":"2001","journal-title":"Stat Med"},{"key":"2019041116320593700_R32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1359\/jbmr.2002.17.1.1","article-title":"Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy.","volume":"17","author":"Sarkar","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2019041116320593700_R33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0002-9343(01)01124-X","article-title":"Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs.","volume":"112","author":"Cummings","year":"2002","journal-title":"Am J Med"},{"key":"2019041116320593700_R34","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/jama.1995.03530100070037","article-title":"A comparison of meta-analytic results using literature vs. individual patient data. Paternal cell immunization for recurrent miscarriage.","volume":"274","author":"Jeng","year":"1995","journal-title":"JAMA"},{"key":"2019041116320593700_R35","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0197-2456(01)00152-0","article-title":"Individual patient-versus literature-based meta-analysis of survival data: time to event and event rate at a particular time can make a difference, an example based on head and neck cancer.","volume":"22","author":"Duchateau","year":"2001","journal-title":"Control Clin Trials"},{"key":"2019041116320593700_R36","first-page":"6","article-title":"Meta-analysis of controlled clinical trials","author":"Whitehead","year":"2002","journal-title":"Chichester, West Sussex, UK: John Wiley & Sons, Ltd.;"},{"issue":"Suppl 1","key":"2019041116320593700_R37","first-page":"S25","article-title":"Risedronate (RIS) preserves trabecular architecture in early postmenopausal women in just 1 year: a paired biopsy study using 3-D MICROCT","volume":"13","author":"Borah","year":"2002","journal-title":"Osteoporos Int"},{"issue":"Suppl 1","key":"2019041116320593700_R38","first-page":"S163","article-title":"Antifracture efficacy of risedronate: prediction by change in bone resorption markers","volume":"16","author":"Eastell","year":"2001","journal-title":"J Bone Miner Res"},{"key":"2019041116320593700_R39","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis.","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med"},{"key":"2019041116320593700_R40","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures.","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"issue":"Suppl 1","key":"2019041116320593700_R41","first-page":"S77","article-title":"Impact of different morphometric criteria for evaluation of incident vertebral deformities","volume":"13","author":"Hoseyni","year":"2000","journal-title":"Osteoporos Int"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/88\/2\/542\/9148518\/jcem0542.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T05:45:36Z","timestamp":1555047936000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/88\/2\/542\/2845076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,1]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2002-020400","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2,1]]}}}